Comparative clinical and molecular landscape of primary and secondary myelofibrosis: Superior performance of <scp>MIPSS70</scp>+ v2.0 over <scp>MYSEC‐PM</scp>
Matteo Guerra, Hélène Pasquer, Rafael Daltro De Oliveira, Juliette Soret‐Dulphy, Nabih Maslah, Lin‐Pierre Zhao, Clémence Marcault, Marine Cazaux, Nicolas Gauthier, Emmanuelle Verger, Nathalie Parquet, William Vainchenker, Emmanuel Raffoux, Stéphane Giraudier, Bruno Cassinat, Jean‐Jacques Kiladjian, Lina Benajiba
Abstract
Comparative clinical characteristics, molecular landscape and prognosis scoring for primary (PMF) and secondary myelofibrosis (SMF).
Topics & Concepts
MyelofibrosisPrimary (astronomy)MedicineInternal medicineAstronomyBone marrowPhysicsMyeloproliferative Neoplasms: Diagnosis and TreatmentAmyloidosis: Diagnosis, Treatment, OutcomesEosinophilic Disorders and Syndromes